Weihua Ren

1.7k total citations
43 papers, 1.1k citations indexed

About

Weihua Ren is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weihua Ren has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Weihua Ren's work include RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (4 papers) and Cancer-related gene regulation (4 papers). Weihua Ren is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related Molecular Pathways (4 papers) and Cancer-related gene regulation (4 papers). Weihua Ren collaborates with scholars based in China, United States and Sweden. Weihua Ren's co-authors include Yabin Wu, Ge‐Liang Xu, Jianfeng Hou, Chenguang Yang, Hanjun Wang, Chao Lü, Weidong Jia, Yongsheng Ge, Jinliang Ma and Ji-Hai Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Weihua Ren

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihua Ren China 20 661 409 258 160 150 43 1.1k
Chungang Liu China 19 822 1.2× 375 0.9× 352 1.4× 111 0.7× 110 0.7× 29 1.2k
Junhong Zhao China 19 805 1.2× 469 1.1× 244 0.9× 129 0.8× 207 1.4× 32 1.2k
Guangyi Wang China 20 478 0.7× 230 0.6× 234 0.9× 195 1.2× 144 1.0× 66 997
Ge‐Liang Xu China 23 661 1.0× 354 0.9× 359 1.4× 216 1.4× 195 1.3× 62 1.3k
Masayuki Nagahashi Japan 14 503 0.8× 287 0.7× 394 1.5× 122 0.8× 155 1.0× 27 1.0k
Nan You China 19 656 1.0× 410 1.0× 250 1.0× 172 1.1× 97 0.6× 61 1.3k
Jianghua Shao China 22 838 1.3× 441 1.1× 453 1.8× 228 1.4× 227 1.5× 51 1.4k
Dongxian Guan China 14 503 0.8× 250 0.6× 255 1.0× 104 0.7× 154 1.0× 17 891
Yang-Hsiang Lin Taiwan 24 834 1.3× 683 1.7× 193 0.7× 185 1.2× 101 0.7× 59 1.3k

Countries citing papers authored by Weihua Ren

Since Specialization
Citations

This map shows the geographic impact of Weihua Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihua Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihua Ren more than expected).

Fields of papers citing papers by Weihua Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihua Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihua Ren. The network helps show where Weihua Ren may publish in the future.

Co-authorship network of co-authors of Weihua Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Weihua Ren. A scholar is included among the top collaborators of Weihua Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihua Ren. Weihua Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Meiling, Cuicui Liu, Ji-Ming Wang, et al.. (2021). Local anesthetic levobupivacaine induces ferroptosis and inhibits progression by up-regulating p53 in non-small cell lung cancer. Aging. 13. 20 indexed citations
3.
Chen, Jiaxuan, Haitao Chen, Zhiwei Liu, et al.. (2021). Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese. SHILAP Revista de lepidopterología. Volume 8. 951–961. 5 indexed citations
4.
Wang, Jialin, Ting Zhang, Song Zhang, et al.. (2020). TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy. Liver International. 40(11). 2834–2847. 23 indexed citations
5.
Zheng, Xubin, Lina Davies Forsman, Yi Hu, et al.. (2020). Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response. Clinical Infectious Diseases. 73(9). e3520–e3528. 34 indexed citations
6.
Ren, Weihua, Jianfeng Hou, Chenguang Yang, et al.. (2019). Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. Journal of Experimental & Clinical Cancer Research. 38(1). 62–62. 265 indexed citations
7.
Wang, Xianbin, Ting Wang, Tingting Pan, et al.. (2019). Senna alexandrina extract supplementation reverses hepatic oxidative, inflammatory, and apoptotic effects of cadmium chloride administration in rats. Environmental Science and Pollution Research. 27(6). 5981–5992. 32 indexed citations
8.
Ren, Weihua, et al.. (2019). MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2. Cell Death and Disease. 10(5). 333–333. 50 indexed citations
9.
10.
Zhao, Weifeng, et al.. (2015). The role and mechanism of WEE1 on the cisplatin resistance reversal of the HepG2/DDP human hepatic cancer cell line. Oncology Letters. 10(5). 3081–3086. 7 indexed citations
11.
Huang, Guobin, et al.. (2014). X-linked inhibitor of apoptosis-associated factor l (XAFl) enhances the sensitivity of colorectal cancer cells to cisplatin. Medical Oncology. 31(12). 273–273. 6 indexed citations
12.
Xu, Ge‐Liang, Weidong Jia, Yongsheng Ge, et al.. (2011). Prognostic significance of osteopontin in hepatocellular carcinoma: A meta‐analysis. International Journal of Cancer. 130(11). 2685–2692. 37 indexed citations
13.
Liu, Wenbin, Ge‐Liang Xu, Weidong Jia, et al.. (2010). Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Medical Oncology. 28(S1). 228–238. 71 indexed citations
14.
Jiang, Deke, Weihua Ren, Lei Yao, et al.. (2010). Meta-analysis of Association Between TP53 Arg72Pro Polymorphism and Bladder Cancer Risk. Urology. 76(3). 765.e1–765.e7. 31 indexed citations
15.
Zhang, Chuanhai, Ge‐Liang Xu, Weidong Jia, et al.. (2010). Activation of STAT3 Signal Pathway Correlates with Twist and E-Cadherin Expression in Hepatocellular Carcinoma and Their Clinical Significance. Journal of Surgical Research. 174(1). 120–129. 48 indexed citations
16.
Jiang, Deke, Lei Yao, Weihua Ren, et al.. (2010). TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis. Medical Oncology. 28(4). 1129–1135. 12 indexed citations
17.
Jiang, Deke, Wenzhang Wang, Weihua Ren, et al.. (2010). TP53 Arg72Pro Polymorphism and Skin Cancer Risk: A Meta-Analysis. Journal of Investigative Dermatology. 131(1). 220–228. 32 indexed citations
18.
Chen, Hao, Weidong Jia, Jiansheng Li, et al.. (2010). Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Medical Oncology. 28(S1). 318–325. 33 indexed citations
19.
Wang, Wei, Ge‐Liang Xu, Weidong Jia, et al.. (2009). Ligation of TLR2 by Versican: A Link Between Inflammation and Metastasis. Archives of Medical Research. 40(4). 321–323. 61 indexed citations
20.
Zhao, Xudong, Weihua Ren, Wenjun Yang, et al.. (2005). Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice. International Journal of Cancer. 118(3). 643–648. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chungang Liu Breakdown of academic impact, for papers by Junhong Zhao Breakdown of academic impact, for papers by Guangyi Wang Breakdown of academic impact, for papers by Ge‐Liang Xu Breakdown of academic impact, for papers by Masayuki Nagahashi Breakdown of academic impact, for papers by Nan You Breakdown of academic impact, for papers by Jianghua Shao Breakdown of academic impact, for papers by Dongxian Guan Breakdown of academic impact, for papers by Yang-Hsiang Lin
Rankless by CCL
2026